| Product Code: ETC6662809 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Canada Opioid Receptor Agonist Market Overview |
3.1 Canada Country Macro Economic Indicators |
3.2 Canada Opioid Receptor Agonist Market Revenues & Volume, 2021 & 2031F |
3.3 Canada Opioid Receptor Agonist Market - Industry Life Cycle |
3.4 Canada Opioid Receptor Agonist Market - Porter's Five Forces |
3.5 Canada Opioid Receptor Agonist Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
3.6 Canada Opioid Receptor Agonist Market Revenues & Volume Share, By Receptor Binding, 2021 & 2031F |
3.7 Canada Opioid Receptor Agonist Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.8 Canada Opioid Receptor Agonist Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Canada Opioid Receptor Agonist Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Canada Opioid Receptor Agonist Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Canada Opioid Receptor Agonist Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic pain conditions in Canada |
4.2.2 Growing awareness and acceptance of opioid therapies for pain management |
4.2.3 Rising geriatric population in Canada leading to higher demand for pain management medications |
4.3 Market Restraints |
4.3.1 Stringent regulations and guidelines on opioid prescriptions in Canada |
4.3.2 Rising concerns and awareness about opioid addiction and abuse |
4.3.3 Increasing preference for alternative pain management therapies |
5 Canada Opioid Receptor Agonist Market Trends |
6 Canada Opioid Receptor Agonist Market, By Types |
6.1 Canada Opioid Receptor Agonist Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Canada Opioid Receptor Agonist Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Canada Opioid Receptor Agonist Market Revenues & Volume, By Fentanyl, 2021- 2031F |
6.1.4 Canada Opioid Receptor Agonist Market Revenues & Volume, By Codeine, 2021- 2031F |
6.1.5 Canada Opioid Receptor Agonist Market Revenues & Volume, By Morphine, 2021- 2031F |
6.1.6 Canada Opioid Receptor Agonist Market Revenues & Volume, By Buprenorphine, 2021- 2031F |
6.1.7 Canada Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Canada Opioid Receptor Agonist Market, By Receptor Binding |
6.2.1 Overview and Analysis |
6.2.2 Canada Opioid Receptor Agonist Market Revenues & Volume, By Full Agonist, 2021- 2031F |
6.2.3 Canada Opioid Receptor Agonist Market Revenues & Volume, By Partial Agonist, 2021- 2031F |
6.3 Canada Opioid Receptor Agonist Market, By Indication |
6.3.1 Overview and Analysis |
6.3.2 Canada Opioid Receptor Agonist Market Revenues & Volume, By Pain management, 2021- 2031F |
6.3.3 Canada Opioid Receptor Agonist Market Revenues & Volume, By Cough Suppression, 2021- 2031F |
6.3.4 Canada Opioid Receptor Agonist Market Revenues & Volume, By Diarrhoea suppression, 2021- 2031F |
6.3.5 Canada Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Canada Opioid Receptor Agonist Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Canada Opioid Receptor Agonist Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.4.3 Canada Opioid Receptor Agonist Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.4 Canada Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Canada Opioid Receptor Agonist Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Canada Opioid Receptor Agonist Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Canada Opioid Receptor Agonist Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Canada Opioid Receptor Agonist Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.5 Canada Opioid Receptor Agonist Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Canada Opioid Receptor Agonist Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Canada Opioid Receptor Agonist Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Canada Opioid Receptor Agonist Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.6.4 Canada Opioid Receptor Agonist Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 Canada Opioid Receptor Agonist Market Import-Export Trade Statistics |
7.1 Canada Opioid Receptor Agonist Market Export to Major Countries |
7.2 Canada Opioid Receptor Agonist Market Imports from Major Countries |
8 Canada Opioid Receptor Agonist Market Key Performance Indicators |
8.1 Number of prescriptions for opioid receptor agonists in Canada |
8.2 Patient satisfaction and pain relief levels with opioid therapies |
8.3 Adoption rate of opioid receptor agonists compared to other pain management medications |
9 Canada Opioid Receptor Agonist Market - Opportunity Assessment |
9.1 Canada Opioid Receptor Agonist Market Opportunity Assessment, By Drugs, 2021 & 2031F |
9.2 Canada Opioid Receptor Agonist Market Opportunity Assessment, By Receptor Binding, 2021 & 2031F |
9.3 Canada Opioid Receptor Agonist Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.4 Canada Opioid Receptor Agonist Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Canada Opioid Receptor Agonist Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Canada Opioid Receptor Agonist Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Canada Opioid Receptor Agonist Market - Competitive Landscape |
10.1 Canada Opioid Receptor Agonist Market Revenue Share, By Companies, 2024 |
10.2 Canada Opioid Receptor Agonist Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here